Analyst Ratings for Sutro Biopharma (STRO)
STRO Rating Summary
STRO Price Target Summary
- Highest: $60.00 (Wedbush)
- Lowest: $34.00 (Citizens)
- Average: $48.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$48.60 (+344.2%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Rating Score: 8.8 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/30/2026 | Wells Fargo | Yanan Zhu | New Coverage | Overweight (N/A) |
49.00 (N/A) |
16.10 (10.94) |
-32.05% | Details |
| 8/6/2026 | Stifel | Laura Prendergast | New Coverage | Buy (N/A) |
48.00 (N/A) |
25.10 (10.94) |
-56.41% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
